Gunawan, Alyssa Claudia V. and Novita, Bernadette Dian (2020) Hyper-coagulation and The Used of Anticoagulant for Patient with COVID-19. Hyper-coagulation and The Used of Anticoagulant for Patient with COVID-19, 6 (2). pp. 103-110. ISSN pISSN: 2338-0373, eISSN: 2623-2723, Jurnal Nasional Terakreditasi Sinta 4
Text (Hyper-coagulation and The Used of Anticoagulant for Patient with COVID-19)
11-Hyper-coagulation_and_.pdf Download (886kB) |
|
Text (Hyper-coagulation and The Used of Anticoagulant for Patient with COVID-19)
10-Hyper-coagulation_and_Hasil Cek Similarity.pdf Download (1MB) |
|
Text (Hyper-coagulation and The Used of Anticoagulant for Patient with COVID-19_peer_review_)
9-R1&2-Hyper-coagulation_and_the_.pdf Download (1MB) |
Abstract
Coronavirus SARS-CoV-2 (COVID-19) infection has become a global infection with high mortality and morbidity rate. The pathophysiology of COVID-19 has not yet clear but associated with increasing proinflammatory cytokines and chemokines that leads to cytokine storm. Cytokine storm leads to increasing coagulation that defined by increasing D-dimer, Prothrombin Time (PT), and activated partial thromboplastin time (aPTT). The use of anticoagulant in patient with COVID-19 decrease the mortality rate and become one of the recommended therapy.
Item Type: | Article |
---|---|
Additional Information: | Jurnal Nasional Terakreditasi Sinta 4 |
Uncontrolled Keywords: | COVID-19, Hyper-coagulation, Anticoagulant |
Subjects: | Medicine |
Divisions: | Journal Publication |
Depositing User: | F.X. Hadi |
Date Deposited: | 02 Nov 2021 05:28 |
Last Modified: | 12 Jan 2022 02:45 |
URI: | https://repository.ukwms.ac.id/id/eprint/27275 |
Actions (login required)
View Item |